-
South Africa coach Conrad says meant no malice with 'grovel' remark
-
Neergaard-Petersen edges out Smith for maiden DP World Tour win
-
Stokes and Jacks lead rearguard action to keep England alive
-
Sri Lanka issues landslide warnings as cyclone toll hits 618
-
McIlroy going to enjoy 'a few wines' to reflect on 'unbelievable year'
-
India nightclub fire kills 25 in Goa
-
Hong Kong heads to the polls after deadly fire
-
Harden moves to 10th on NBA all-time scoring list in Clippers defeat
-
Number's up: Calculators hold out against AI
-
McIntosh, Marchand close US Open with 200m fly victories
-
Divided US Fed set for contentious interest rate meeting
-
India nightclub fire kills 23 in Goa
-
France's Ugo Bienvenu ready to take animated 'Arco' to Oscars
-
Trump's Pentagon chief under fire as scandals mount
-
England's Archer takes pillow to second Ashes Test in 'shocking look'
-
Australia skipper Cummins 'good to go' for Adelaide Test
-
Mexico's Sheinbaum holds huge rally following major protests
-
Salah tirade adds to Slot's troubles during Liverpool slump
-
Torres treble helps Barca extend Liga lead, Atletico slip
-
PSG thump Rennes but Lens remain top in France
-
Salah opens door to Liverpool exit with 'thrown under the bus' rant
-
Two eagles lift Straka to World Challenge lead over Scheffler
-
Messi dazzles as Miami beat Vancouver to win MLS title
-
Bielle-Biarrey strikes twice as Bordeaux-Begles win Champions Cup opener in S.Africa
-
Bilbao's Berenguer deals Atletico another Liga defeat
-
Salah opens door to Liverpool exit after being 'thrown under the bus'
-
Bethlehem Christmas tree lit up for first time since Gaza war
-
Slot shows no sign of finding answers to Liverpool slump
-
New Zealand's Robinson wins giant slalom at Mont Tremblant
-
Liverpool slump self-inflicted, says Slot
-
Hundreds in Tunisia protest against government
-
Mofokeng's first goal wins cup final for Orlando Pirates
-
Torres hat-trick helps Barca down Betis to extend Liga lead
-
Bielle-Biarrey strikes twice as Bordeaux win Champions Cup opener in S.Africa
-
Liverpool humbled again by Leeds fightback for 3-3 draw
-
'Democracy has crumbled!': Four arrested in UK Crown Jewels protest
-
Contenders plot path to 2026 World Cup glory as FIFA reveals tournament schedule
-
Inter thump Como to top Serie A ahead of Liverpool visit
-
Maresca fears Chelsea striker Delap faces fresh injury setback
-
Consistency the key to Man City title charge – Guardiola
-
Thauvin on target again as Lens remain top in France
-
Greyness and solitude: French ex-president describes prison stay
-
Frank relieved after Spurs ease pressure on under-fire boss
-
England kick off World Cup bid in Dallas as 2026 schedule confirmed
-
Milei welcomes Argentina's first F-16 fighter jets
-
No breakthrough at 'constructive' Ukraine-US talks
-
Bielle-Biarrey double helps Bordeaux-Begles open Champions Cup defence with Bulls win
-
Verstappen looking for a slice of luck to claim fifth title
-
Kane cameo hat-trick as Bayern blast past Stuttgart
-
King Kohli says 'free in mind' after stellar ODI show
| RIO | -0.92% | 73.06 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| RBGPF | 0% | 78.35 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| BP | -3.91% | 35.83 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| RYCEF | -0.34% | 14.62 | $ |
The race to link our brains to computers is hotting up
Brain implants have long been trapped in the realm of science fiction, but a steady trickle of medical trials suggests the tiny devices could play a big part in humanity's future.
Billions of dollars are flowing into a clutch of specialist companies hunting for treatments for some of the most debilitating ailments.
And pioneering studies have already yielded results.
In May, a Dutchman paralysed in a motorcycle accident regained the ability to walk thanks to implants that restored communication between his brain and spinal cord.
That experiment was one of several eye-catching trials that have helped spark a huge buzz around the industry.
In the decade to 2020, investors poured more than $30 billion into neurotechnology more widely, according to UNESCO.
And the money has continued to flood in thanks, in part, to rapid improvements in artificial intelligence (AI), used by researchers to interpret the data from the implants.
Tech titan Elon Musk has refocused some energy on his Neuralink firm after it received permission in May to test its implants on humans, helping it to raise $280 million in funding.
And other firms with less prominent bosses are proliferating, offering hope for sufferers of ailments from rare nerve diseases to severe epilepsy.
- 'Turning point' -
Synchron, a company formed more than a decade ago, raised $75 million this year with backing from the likes of Microsoft co-founder Bill Gates and Amazon's Jeff Bezos.
The firm got permission from the US authorities in 2021 to test its implant, and has since rolled it out to nine people with Amyotrophic Lateral Sclerosis (ALS) -- the motor neurone disease that physicist Stephen Hawking suffered from.
Its implant allows patients to use messaging apps or browse online using only eye movements and thoughts.
One of the big selling points is that, unlike other implants, it does not require invasive surgery.
The first goals of the Synchron test, said Dr David Putrino, who oversaw the medical trial at Mount Sinai Hospital in New York, were to make sure the implant was safe and could monitor the brain over long periods.
On both fronts, he said, the trial had been a success.
Synchron founder Tom Oxley thinks the technology, known as brain-computer interface (BCI), is now at a "turning point".
The industry must aim to make the implants widely accessible, he told AFP.
- Brain attack -
There are still pretty hefty impediments before that can happen, not least that the most powerful results often come from the most invasive implants.
For example, a patient in the US, Ian Burkhart, who was left paralysed from the neck down after a diving accident, told AFP that getting an implant that allowed him to control his arms and hands again was a "magical moment".
But he was only ever able to do that in a lab and the implant, known as a Utah array, was far from comfortable.
"The brain doesn't like having stuff inside it," said Michael Platt, professor of neuroscience at the University of Pennsylvania.
"And so the immune system of the brain will attack these devices," he said of the Utah arrays.
As the implants get covered by cells, they are less able to transmit signals from the brain and they function less well.
Although far less advanced, some researchers are pinning their hopes on techniques that do not involve implants.
In May, scientists at the University of Texas at Austin said they had used brain scans and AI modelling to glean "the gist" of what people were thinking.
The technique relied heavily on the GPT models developed by OpenAI, which are capable of analysing massive chunks of data increasingly quickly.
But such research is at the very earliest stage and involves patients spending as much as 16 hours each time in an MRI scanner.
- Musk's telepathy plan -
While most players in the field are exclusively concerned with medical uses for neurotechnology, Musk is different.
The maverick tycoon is touting the possibility of telepathy, using the technology to store memories or to enable humans to continue their existence without their bodies.
"In the future you will be able to save and replay memories," he told a Neuralink event in 2020.
"You could potentially download them into a new body or into a robot body."
These claims remain far from reality but this has not stopped Musk from going even further.
He sees implants as a way of enhancing humans -- a vital move, he thinks, if our species is to co-exist with superintelligent machines.
"That might be the most important thing that a device like this achieves," he said.
A.Taylor--AT